Table 1.

Treatment and outcome measurement schedules during our pilot study

Outcome measures	Screening	Week 0 (baseline)	Week 1	Week 2	Week 3	Week 7
Screening test	V
Sociodemographic characteristics	V
Randomization		V
Laboratory test	V				V
MA treatment		V	V	V
NSAIDs prescription		V	V	V
Visual analog scale	V	V	V	V	V	V
Neck Disability Index		V	V	V	V	V
EQ-5D questionnaire		V	V	V	V	V
PGIC scale			V	V	V	V
Adverse events		V	V	V	V	V
Credibility assessment					V
Total safety assessment					V

NSAIDs nonsteroidal anti-inflammatory drugs, EQ-5D EuroQol 5-dimension, PGIC Patient’s Global Impression of Change